OverviewChartNewsTraderScreen

HSBC TUR.WAR.OP.END. 5CV/  DE000HS6CG97  /

gettex Zettex2
2024-10-31  9:36:59 PM Chg.-0.0500 Bid9:59:08 PM Ask- Underlying Strike price Expiration date Option type
0.2200EUR -18.52% 0.2200
Bid Size: 10,000		 -
Ask Size: -		 CureVac NV 2.5999 USD 2078-12-31 Call
GlobeNewswire 08-26 Simtra BioPharma Solutions Appoints Dr. Lidia Serina as Head of Development Sciences
TeleTrader 2022-07-05 CureVac sues BioNTech over vaccine technology
GlobeNewswire 2022-03-25 US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire 2022-01-13 GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration o...
GlobeNewswire 2022-01-11 GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply ...
GlobeNewswire 2021-12-17 Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatme...
GlobeNewswire 2021-12-11 Annual Changes to the Nasdaq Biotechnology Index
GlobeNewswire 2021-12-07 Ondine Biomedical appoints new Board of Directors
GlobeNewswire 2021-12-07 Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutation...
GlobeNewswire 2021-12-02 Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV...
GlobeNewswire 2021-11-17 GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COV...
GlobeNewswire 2021-11-12 Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovim...
TeleTrader 2021-10-12 CureVac abandons COVID shot development
GlobeNewswire 2021-07-28 GSK and Vir Biotechnology Announce Joint Procurement Agreement with European Commission for COVID-19...
TeleTrader 2021-06-30 CureVac vaccine only 48% effective against COVID - final data
GlobeNewswire 2021-06-21 GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for...
TeleTrader 2021-06-20 EU reconsidering CureVac deal following study - report
TeleTrader 2021-06-18 WHO official: Delta variant globally dominant
TeleTrader 2021-06-17 Europe closes mixed on Fed's hawkish forecast
TeleTrader 2021-06-16 CureVac study shows COVID jab only 47% efficient
TeleTrader 2021-06-02 Germany to increase jab supply to prevent future pandemics
GlobeNewswire 2021-05-27 GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from t...
GlobeNewswire 2021-05-26 Immatics Announces Changes to its Board of Directors
TeleTrader 2021-05-23 CureVac expanding output before Q2 approval - spox
GlobeNewswire 2021-05-21 CORRECTION -- EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For t...